HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Probe Finds Issues With Nu Skin Compliance, Not Business Model

This article was originally published in The Rose Sheet

Executive Summary

Nu Skin’s direct-selling model in China, the legality of which some investors have questioned, was not cited in fines levied on the company totaling $540,000. Firm says it “is not aware of any other material enforcement investigations currently pending” in the country, which accounted for nearly half of Nu Skin’s fiscal 2013 fourth-quarter sales.

You may also be interested in...



In Brief: PCPC Seeks Member Solidarity; Goop Skin Care; Nu Skin Update; More

Gwyneth Paltrow's Goop brand launches its first product line, a six-piece luxury skin-care collection featuring certified organic ingredients, developed in collaboration with Juice Beauty. Meanwhile, Nu Skin settles a shareholder class action concerning its China business, KleanColor recalls some dirty mascara and PCPC's chair urges members to unite with "one voice" in legislative reform efforts.

Avon Leaves U.S. Direct Selling Association, Cites Code-Of-Ethics Differences

In a letter to its direct-selling colleagues, Avon outlines components of its direct-selling policy that it claims provide better protections to sales representatives than U.S. DSA’s Code of Ethics, which needs updating, the firm says. The move may help to insulate Avon from pressures facing the industry and serve to reassure the company’s existing and would-be sales reps at a time when their ranks are dwindling.

In Brief: FDA Cosmetics Twitter; Eyebrow Makeup Sales; Olay ProX Study

FDA’s Office of Cosmetics and Colors starts tweeting, NPD says prestige eyebrow makeup sales are an opportunity for growth. More news in brief.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel